Autres langues Vitrolife AB

Actions

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:38 23/04/2024			Varia. 5j.	Varia. 1 janv.
165,3 ^SEK	+1,97 %		-11,41 %	-15,10 %

18/04	Transcript : Vitrolife AB, Q1 2024 Earnings Call, Apr 18, 2024
18/04	Vitrolife AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Vitrolife Q1 update - Entering 2024 with low growth	22/04
Vitrolife : Item 8b Auditor statement remuneration	19/04
Nordic Stocks Closed Down Thursday; Arjo Series B Fell Furthest	18/04
Interim report Q1, 2024: Strong growth in APAC and solid margins	18/04
Vitrolife AB Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04
Correction: Notice to attend the Annual General Meeting of Vitrolife AB (publ)	04/04
Conference call interim report	04/04
Vitrolife : Item 18 proposal for LTIP 2024	02/04
Vitrolife : Item 18 Appendix 1 to proposal for LTIP 2024	02/04
Vitrolife Group Annual and Sustainability Report 2023	27/03
Vitrolife : Notice Annual General Meeting Vitrolife AB 2024	27/03
Notice to attend the Annual General Meeting of Vitrolife AB (publ)	26/03
Memphasys Secures Additional Order for Fertility Device System in Japan; Shares Jump 9%	18/03
Vitrolife : 6 March 2024, Carnegie Healthcare Seminar Stockholm	06/03
Nordic Shares Rose Monday; Vitrolife Topped Leaders	05/02
Vitrolife Q4 - Strong margins and gradually improving Genetic Services	05/02
Fourth quarter and full year report, 2023: Continued growth with margin expansions	02/02
Vitrolife AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02/02
Vitrolife AB Reports Earnings Results for the Full Year Ended December 31, 2023	02/02
Vitrolife AB Proposes Dividend, Payable on 3 May 2024	02/02

Aucun résultat pour cette recherche

Vitrolife AB (publ) : Pionnier de la fécondation in vitro

Le 25 juillet 2023 à 10:20